Headline
The latest stories from AHA Today.
Medtronic's HeartWare Ventricular Assist Device system recall: Get the latest updates on controller port pin damage and pump weld defect. Stay informed.
The Centers for Medicare & Medicaid Services has pushed back the start date of the radiation oncology model. Learn more from AHA News.
AHA, in comments today to the Centers for Medicare & Medicaid Services, voiced support for the agency’s new rural emergency hospital designation, particularly its potential value in the area of maternal health. “It is undeniable that access to maternal and child care services is lacking in…
The Centers for Medicare & Medicaid Services yesterday released a CMCS Informational Bulletin to remind states of existing federal guidance related to reimbursement of Ground Emergency Medical Transportation services in Medicaid.
The deadline to comment on the Centers for Medicare & Medicaid Services’ proposed rule on Clinical Laboratory Improvement Amendments-certified labs was extended through Sept. 26, according to the Federal Register.
A federal judge in Idaho Aug. 24 preliminarily enjoined an Idaho law in circumstances where it would conflict with the requirements of the Emergency Medical Treatment and Active Labor Act. The court concluded that the Idaho law lacks “a cutout for EMTALA-required care,” and thus “would inject…
Former AHA Chair and Distinguished Service Award recipient Sister Mary Roch Rocklage passed away yesterday. She was 87. Rocklage was considered the “modern day foundress” of the Mercy health care system, serving the ministry for 65 years, including as Mercy’s first president and CEO and later its…
The Institute for Diversity and Health Equity and AHA Community Health Improvement are accepting content proposals for the annual Accelerating Health Equity Conference, which will be held May 16-18, 2023, in Minneapolis.
A federal judge in Texas Aug. 23 blocked the Biden Administration from enforcing new guidance related to the Emergency Medical Treatment and Active Labor Act, which it issued following the Supreme Court’s decision in Dobbs v. Jackson Women’s Health Organization. The judge held the Department of…
Pfizer applies for EUA for variant-tailored booster; unveils new efficacy data for youngest children
Pfizer yesterday announced its application for an emergency use authorization for a COVID-19 vaccine booster that is designed to protect against the SARS-CoV-2 omicron variant. The booster is meant for the 12 and older age group.